Clinical Trial Update: Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the efficacy and safety of rimonabant for weight loss and reducing binge episodes in obese patients has completed. The update summariz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder
• Obesity

Drugs mentioned

• Rimonabant (rimonabant)

Snippet

Sponsor: Sanofi | Conditions: Obesity, Eating Disorders | Phase 3 | Status: COMPLETED